Kerry

U.S.A

Indo Livestock Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Tablet

Grade :

Brand Name : Disintequik™ ODT

Application : Co-Processed Excipients

Excipient Details : Orally Disintegrating Tablets

Pharmacopoeia Ref : USP/NF

Technical Specs :

Ingredient(s) : Crospovidone, Dextrose, Lactose, Mannitol

Dosage Form : Tablet

Grade :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Crospovidone, Dextrose, Lactose, Mannitol

Dosage Form : Tablet

Category : Co-Processed Excipients

Brand : DISINTEQUIK™ ODT

Applications : Orally Disintegrating Tablets

Pharmacopoeia Ref : USP/NF

Technical Specs : Not Available

Grade : Not Available

Looking for Pentahydrate, Ceftazidime? Find Co-Processed Excipients used in Pentahydrate, Ceftazidime to address drug delivery challenges on PharmaCompass.

Pentahydrate, Ceftazidime

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

44 API Suppliers

18 USDMF

16 CEP/COS

6 JDMF

5 EU WC

4 KDMF

4 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

238 FDF Dossiers

42 FDA Orange Book

100 Europe

6 Canada

16 South Africa

74 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL

INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 20MG BASE/ML

INJECTABLE;INJECTION - EQ 40MG BASE/ML

INJECTABLE;INJECTION - EQ 1GM BASE

INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Actylis

1 Kerry

1 Microlex e.U

1 Pluviaendo

1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Parenteral

2 Fillers, Diluents & Binders

1 Co-Processed Excipients

1 Taste Masking

DIGITAL CONTENT

25 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

82 Regulatory FDF Prices

9 Annual Reports

MARKET PLACE

22 APIs

20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents

4 US Exclusivities

16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM

4 Others

Filters

Pentahydrate, Ceftazidime

01

Kerry

Kerry

INJECTABLE;INJECTION - 1GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 500MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 6GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons